市場調査レポート

商品コード

1491747

末梢インターベンション市場規模、シェア、成長分析、製品別、用途別、最終用途別- 産業予測、2024年～2031年

Peripheral Interventions Market Size, Share, Growth Analysis, By Product(Catheters, Sheath), By Application(Venous Thromboembolism, Peripheral Artery Disease), By End-Use(Hospitals, Ambulatory Surgical Centres) - Industry Forecast 2024-2031

出版日: 2024年06月06日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 810,158円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 947,732円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,085,306円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=152.86円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の末梢インターベンション市場規模は2022年に86億8,000万米ドルと評価され、2023年の94億2,000万米ドルから2031年には180億9,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは8.50％で成長する見通しです。

高血圧、糖尿病、肥満、喫煙、炭水化物の多い食事といった要因がさまざまなCVDの要因となっています。この健康上の懸念は、特に新興市場におけるカテーテル検査室（カテラボ）の世界の急増につながり、末梢インターベンションを専門とするヘルスケア専門家の増加を伴って、業界の成長を後押ししています。カテーテル検査室は心血管系疾患の診断と治療において重要な役割を担っており、特に発展途上国ではその利用が増加しており、ハイブリッド型カテーテル検査室の出現は最近の重要な進歩を示しています。これらのハイブリッド施設は、心臓や末梢のインターベンションだけでなく、神経学的、電気生理学的、その他の臨床処置にも適応可能であり、増加傾向にあります。特にインドでは、血管形成術を含む末梢インターベンションの急増に伴ってカテラボの数が大幅に増加しており、その結果、世界のヘルスケア支出を押し上げています。このような処置に対する需要の継続的な増加が予測されることから、専門家やカテーテル検査室の拡大が業界の成長をさらに促進すると予想されます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Johnson & Johnson（United States）
Medtronic（United States）
Becton Dickinson（United States）
Boston Scientific Corporation（United States）
Abbott Laboratories（United States）
Terumo Corporation（Japan）
Cook Medical（United States）
Cardinal Health（United States）
C. R. Bard（United States）
Teleflex Incorporated（United States）
AngioDynamics Inc.（United States）
B. Braun Melsungen AG（Germany）
Asahi Intecc Co., Ltd.（Japan）
Penumbra, Inc.（United States）
Stryker Corporation（United States）
Terumo Interventional Systems（United States）
Olympus Corporation（Japan）
Nipro Corporation（Japan）
Endologix Inc.（United States）
Merit Medical Systems, Inc.（United States）

Product Code: SQMIG35D2214

Global Peripheral Interventions Market size was valued at USD 8.68 billion in 2022 and is poised to grow from USD 9.42 billion in 2023 to USD 18.09 billion by 2031, growing at a CAGR of 8.50% during the forecast period (2024-2031).

The escalating prevalence of cardiovascular disorders (CVD) is becoming a major driver for demand in peripheral interventions, fueled by factors like hypertension, diabetes, obesity, smoking, and diets rich in carbohydrates contributing to various CVD types. This health concern has led to a proliferation of catheterization laboratories (cath labs) globally, especially in emerging markets, accompanied by a rise in healthcare professionals specializing in peripheral interventions, thus bolstering industry growth. Cath labs play a vital role in diagnosing and treating cardiovascular conditions, with their utilization increasing, particularly in developing nations, and the advent of hybrid cath labs marking a significant recent advancement. These hybrid facilities, adaptable for cardiac and peripheral interventions as well as neurological, electrophysiological, and other clinical procedures, are on the rise. Notably, India has seen a substantial increase in cath lab numbers, accompanied by a significant surge in peripheral intervention procedures, including angioplasties, consequently driving up global healthcare expenditure. With a projected continued rise in demand for these procedures, the expansion of specialized experts and catheterization laboratories is expected to further propel industry growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Interventions Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Interventions Market Segmental Analysis

The global peripheral interventions market is segmented on the basis of product, application, end-use, and region. By product, the market is segmented into catheters, sheath, stents, bare-metal stents, drug-eluting stents, guide wires, atherectomy devices, embolic devices, thrombectomy devices, IVC filters and others. By application, the market is segmented into venous thromboembolism, peripheral artery disease and others. By end-use, the market is segmented into hospitals, ambulatory surgical centers, catheterization laboratories and others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Peripheral Interventions Market

The increasing frequency of cardiovascular disorders, encompassing conditions like peripheral artery disease (PAD), is fueling the demand for solutions targeting peripheral health. This surge in cardiovascular issues is mainly linked to risk factors such as hypertension, diabetes, obesity, and a sedentary lifestyle.

Restraints in the Global Peripheral Interventions Market

Limited market accessibility stems from the high costs associated with peripheral intervention treatments for certain individuals, potentially hindering access to essential care, particularly in affluent regions with expensive healthcare systems.

Market Trends of the Global Peripheral Interventions Market

The rising demand for invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures, is driving the growth of hybrid catheterization labs, which are becoming increasingly popular. This expanding market is fueled by the versatility and adaptability of these facilities.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Patent Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Peripheral Interventions Market by Product

Market Overview
Catheters
Sheath
Stents
Bare-meta Stents
Drug-eluting Stents
Guide Wires
Atherectomy Devices
Embolic Devices
Thrombectomy Devices
IVC Filters
Others

Peripheral Interventions Market by Application

Market Overview
Venous Thromboembolism
Peripheral Artery Disease
Others

Peripheral Interventions Market by End-use

Market Overview
Hospitals
Ambulatory Surgical Centres
Catheterization Laboratories
Others

Peripheral Interventions Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C. R. Bard (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Interventional Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

末梢インターベンション市場規模、シェア、成長分析、製品別、用途別、最終用途別- 産業予測、2024年～2031年

Peripheral Interventions Market Size, Share, Growth Analysis, By Product(Catheters, Sheath), By Application(Venous Thromboembolism, Peripheral Artery Disease), By End-Use(Hospitals, Ambulatory Surgical Centres) - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

製品別：末梢インターベンション市場

用途別：末梢インターベンション市場